Engineered Meganucleases Specific for Recognition Sequences in the Hepatitis B Virus Genome
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2017/056638, filed Oct 13, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,662,416 | Engineered Meganucleases Specific for Recognition Sequences in the Hepatitis B Virus Genome In force · High confidence | Precision Biosciences, Inc. | In force | High confidence | ||
| US 10,851,358 | Engineered Meganucleases Specific for Recognition Sequences in the Hepatitis B Virus Genome In force · Medium confidence | Precision Biosciences, Inc. | In force | Medium confidence | ||
| US 11,274,285 | Engineered Meganucleases Specific for Recognition Sequences in the Hepatitis B Virus Genome In force · High confidence | Precision Biosciences, Inc. | In force | High confidence | ||
| Application 17/665,265 | Engineered Meganucleases Specific for Recognition Sequences in the Hepatitis B Virus Genome Abandoned Abandoned Feb 28, 2024 | Precision Biosciences, Inc. | Abandoned | Abandoned Feb 28, 2024 | ||
| Application 18/424,277 | Engineered Meganucleases Specific for Recognition Sequences in the Hepatitis B Virus Genome Abandoned Abandoned Jun 25, 2025 | Precision Biosciences, Inc. | Abandoned | Abandoned Jun 25, 2025 | ||
| Application 19/029,948 | Engineered Meganucleases Specific for Recognition Sequences in the Hepatitis B Virus Genome Pending Not granted | Precision Biosciences, Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Precision Biosciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.